Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer.
Doescher J, Weissinger SE, Schönsteiner SS, Lisson C, Bullinger L, Barth TF, Leithäuser F, Mueller-Richter U, Laban S, Hoffmann TK, Möller P, Lennerz JK, Schuler PJ.
Doescher J, et al. Among authors: schonsteiner ss.
Immunotherapy. 2019 Oct;11(14):1193-1203. doi: 10.2217/imt-2019-0041. Epub 2019 Aug 29.
Immunotherapy. 2019.
PMID: 31462115
Clinical Trial.